白宫新冠肺炎应对协调员Ashish Jha博士周日表示，拜登政府正在通过确保“新一代”疫苗和获得治疗和检测，为今年秋天和冬天可能出现的新冠肺炎感染浪潮做准备，但他强调，该计划取决于国会的资金。

“我们有资源，”杰哈告诉美国广播公司“本周”联合主播玛莎·拉达茨。“我一直在谈论国会需要加强和资助这一努力的原因之一是，如果他们不这样做，玛莎，我们将在没有下一代疫苗、没有治疗和诊断的情况下进入秋季和冬季。这将使我们更加难以照顾和保护美国人民。”

Jha一直在敦促立法者批准乔·拜登总统的请求要求增加225亿美元的COVID资金，警告说国家已经花费了大量资金用于疫情检测和治疗，包括去年美国救援计划签署成为法律的1.9万亿美元。然而，由于共和党的反对，这一要求在国会仍被搁置。

与此同时，美国正在经历另一波COVID浪潮，几乎每个州的病例都在增加。根据最新数据，官方感染人数每天超过10万，与COVID相关的七天平均住院人数比前一周增加了约24%疾病控制中心数据。专家说，这种激增部分是由于病毒的持续变种和亚变种，其中一些越来越具有传染性。白宫表示，疫苗接种仍然是预防严重疾病死亡和减少传播的关键策略。

“我们所知道的是，这种病毒进化得非常快，它的每一次迭代都有越来越多的免疫逃逸，这使得这种病毒更难被遏制，除非我们继续给人们接种疫苗，并让人们了解最新情况，”Jha在“本周”节目中说

随着最近COVID病例和住院人数的激增，Jha说接种疫苗或加强剂至关重要，他“非常强烈”地认为美国人应该再次在室内戴上口罩。

“当你在室内时，你应该戴上口罩，”他说。“首先，我的建议是，如果你在过去五个月内没有接种疫苗，如果你没有加强免疫，你需要现在就去做。”

Raddatz向Jha追问，考虑到他们一贯的建议没有深入到公众的各个方面，政府是否考虑了一项新的公共卫生战略。

Anna Moneymaker/Getty Images

白宫冠状病毒应对协调员Ashish Jha博士在每日新闻发布会上发言..

但是，Raddatz问道，考虑到他们一贯的建议(疫苗、口罩)没有向公众的各个方面传播，政府是否考虑过另一种公共卫生策略?

“你们一个月又一个月地说，戴上口罩，接种疫苗，注射加强剂，但这些数字并没有真正移动。那么你们对另一个计划有什么样的讨论?”拉达茨说。

“我们希望帮助人们理解，我们正处于一个与两年前不同的时刻，对吗?我们正处在一个很多人接种疫苗和加强免疫的阶段，在这个阶段，我们确实有广泛可用的疗法，”Jha说。

“因此，现在的关键讨论是:我们如何帮助美国人度过这一时刻?玛莎，这真的很重要，我们如何为未来的变种做准备，我们如何为这种病毒的演变做准备，我们如何确保我们有资源这样做，以便我们可以在这种病毒继续演变时保护美国人?”

随着疾病控制和预防中心本周支持5至11岁的儿童在首次注射后至少五个月有资格接受加强注射，Raddatz敦促Jha在尚不符合资格的儿童可以接受第一次注射时进行。

“但5岁及以下怎么办?我们要多久才能看到呢?”拉达茨问道。

“据我所知，Moderna已经完成了申请，FDA(美国食品药品监督管理局)专家正在密切关注这些数据。我的期望是，一旦分析完成，可能在接下来的几周内，我们将得到委员会以外的专家，”Jha说，他指的是FDA咨询委员会。"之后，食品和药物管理局将做出决定."

“我的希望是，它将在未来几周内到来，”他说。

Jha还谈到了另一种越来越受关注的传染病:猴痘。拜登最近表示，这是“每个人都应该关心的事情。”

然而，Jha警告说，COVID疫情和最新的猴痘病例之间存在重大差异，迄今为止，美国已有两例确诊感染病例，分别发生在马萨诸塞州和纽约州。

Jha指出，美国配备了针对它的疫苗。世界各地对猴痘的研究由来已久。

“我不会感到惊讶，玛莎，如果我们在未来几天看到更多的情况。我认为总统是对的:任何时候我们有这样的传染病爆发，我们都应该注意，”他说。“但我觉得这是一种我们了解的病毒。我们有针对它的疫苗，我们有针对它的治疗方法，它的传播与新型冠状病毒非常不同。它不像COVID那样具有传染性。”

Dr. Jha urges Congress to fund 'new generation' of COVID vaccines for possible fall surge

The Biden administration is planning for a likely wave of COVID-19 infections this fall and winter by ensuring both a "new generation" of vaccines and access to treatment and testing, White House COVID-19 Response Coordinator Dr. Ashish Jha said on Sunday -- but he stressed that plan depended on congressional funding.

"We have the resources," Jha told ABC "This Week" co-anchor Martha Raddatz. "One of the reasons I've been talking a lot about the need for Congress to step up and fund this effort is if they don't, Martha, we will go into the fall and winter without that next generation of vaccines, without treatments and diagnostics. That's going to make it much, much harder for us to take care of and protect Americans."

Jha has been urging lawmakers to approve President Joe Biden'srequestfor an additional $22.5 billion in COVID funding, warning that the nation has spent much of the money dedicated to pandemic testing and treatments, including what was in the $1.9-trillion American Rescue Plan signed into law last year. That request, however, remains stalled in Congress amid GOP opposition.

Meanwhile the U.S. is experiencing another COVID wave, with cases rising in nearly every state. Official infection numbers are up to more than 100,000 per day and COVID-related seven-day average hospitalizations rose by around 24% from the prior week, according to the latestCDCdata. Experts say this surge is due in part to the virus' continued variants and subvariants, some of which are increasingly contagious. Vaccination, the White House says, remains a key strategy at preventing severe illness death and lessening the spread.

"What we know is that this virus is evolving very quickly and every iteration of it has more and more immune escape [which] makes it harder for this virus to be contained unless we continue vaccinating people and keeping people up-to-date," Jha said on "This Week."

With the recent spikes in COVID cases and hospitalization numbers, Jha said vaccination or boosters were crucial and that he felt "very strongly" Americans should wear masks indoors again.

"When you're in an indoor space, you should be wearing a mask," he said. "First and foremost, my advice is if you have not gotten vaccinated in the last five months, if you have not gotten boosted, you need to go out to do that now."

Raddatz pressed Jha on whether the administration had considered a new public health strategy considering their consistent advice had not broken through to all quarters of the public.

But, Raddatz asked, had the administration been considering another public health strategy considering their consistent advice (vaccines, masking) had not broken through to all quarters of the public?

"You said month after month after month, put your masks on, get a vaccine, get a booster, but the numbers aren't really moving. So what kind of discussions do you have about another plan?" Raddatz said.

"We want to help people understand that we are in a different moment than we were two years ago, right? We are at a point where lots of people are vaccinated and boosted, where we do have widespread therapies available," Jha said.

"And so the key discussion now is: How do we help Americans through this moment? And, this is really important, Martha, how do we prepare for future variants, how do we prepare for the evolution of this virus, and how do we make sure we have the resources to do it so we can protect Americans as this virus continues to evolve?"

With the Centers for Disease Control and Prevention this week backing booster eligibility for children 5 to 11 at least five months after their initial shots, Raddatz pressed Jha on when kids not yet eligible may be able to get their first shots.

"But what about 5 and under? How soon might we see that?" Raddatz asked.

"What I know is that Moderna has completed its application, those data are being looked at very closely right now by FDA [Food and Drug Administration] experts. And my expectation is that as soon as that analysis is done, probably within the next few weeks, we're going to get that expert outside committee," Jha said, referring to an FDA advisory committee. "And then after that, FDA's going to make a decision."

"My hope is that it's going to be coming in the next few weeks," he said.

Jha also talked about another infection that has gained increasing attention: monkeypox. Biden recently said it was "something that everybody should be concerned about."

Jha, however, cautioned that there were significant differences between the COVID pandemic and the latest monkeypox cases, which have two confirmed infections so far in the U.S.-- in Massachusetts and New York.

The U.S. is equipped with vaccines against it, Jha noted. And monkeypox has long been studied around the world.

"I would not be surprised, Martha, if we see a few more cases in the upcoming days. And I think the president's right: Anytime we have an infectious disease outbreak like this we should all be paying attention," he said. "But I feel like this is a virus we understand. We have vaccines against it, we have treatments against it, and it spreads very differently than SARS-CoV-2. It's not as contagious as COVID."